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Glibenclamide significantly stimulated the incorporation of [3H]thymidine into DNA of fetal rat pancreatic 
islets at a physiological (5.5 mM) but not at a high (22 mM) glucose concentration. There was no significant 
stimulation of insulin release under these conditions. In contrast, the drug-stimulated insulin release from 
adult islets cultured at 5.5 mM glucose but had no effect on their DNA synthesis. The observations uggest 
that insulin secretion and DNA synthesis may be dissociated in rat pancreatic islets. 
Rat pancreatic islet P-Cell replication 
1. INTRODUCTION 
The stimulation of insulin release by pancreatic 
P-cells in response to sulphonylureas is well 
documented in vivo [l] and in vitro [2]. However, 
the precise mechanism behind this stimulation re- 
mains unclear. Evidence suggests that these com- 
pounds stimulate insulin release by mechanisms 
not involving increased metabolic fluxes [3]. There 
is also no agreement in the literature concerning 
the effects of sulfonylureas on the growth of pan- 
creatic &cells. Previous observations in vitro sug- 
gested that tolbutamide treatment of monolayer 
cultures of newborn rat pancreas caused a 3 to 
4-fold increase in &cell replication [4], though not 
in the isolated pancreatic islets of mice [5]. 
This study attempts to shed more light on the 
long-term actions of a hypoglycaemic sulfonylurea 
glibenclamide, with particular attention to the rate 
of DNA synthesis and insulin release in the P-cell. 
2. MATERIALS AND METHODS 
2.1. Tissue culture 
Virgin female Wistar rats (200-250 g) were caged 
with males and sacrificed 21.5 days after con- 
firmed mating. In this strain the duration of 
Insulin release Glibenclamide 
pregnancy is 22 days. Fetuses were immediately 
obtained by hysterotomy. Cultures of the fetal 
pancreas were prepared as in [6] and incubated at 
37°C for 5 days in a humidified atmosphere of 5% 
CO2 in air. The culture medium RPM1 1640 (Gib- 
co), supplemented with 10% fetal calf serum was 
changed daily, and after 5 days the islets were 
transferred to fresh medium using a braking 
pipette [6]. 
medium supplemented with 5.5 or 22 mM glucose 
with or without the addition of glibenclamide 
(HB419, Hoechst). Islets from adult rat pancreas 
were obtained by a standard collagenase treatment 
[7] and tissue culture was performed at 5.5 or 11 
mM glucose concentrations. 
2.2. Insulin release 
Groups of 20 fetal or 10 adult islets were 
transferred to multiwell tissue culture plates (Lin- 
bro) containing 200 ,ul Krebs-Ringer bicarbonate 
buffer (pH 7.4) supplemented with 5.5 mM glucose 
and 5 PM glibenclamide. Incubation was for a 
period of 90 min at 37°C in a humidified atmo- 
sphere of 5% CO2 in air. Subsequently, 100 ~1 ali- 
quots of the incubation medium were withdrawn 
and stored at -80°C until assayed for insulin as in 
ta. 
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2.3. Islet DNA synthesis 
Groups of islets were transferred to dishes con- 
taining 5 ml of the appropriate culture medium 
and 1 &i/ml [methyl-3H]thymidine (spec. act. 5 
Ci/mmol, Radiochemical Centre, Amersham) and 
maintained in culture for a further 24 h. Islets were 
then washed in Hanks’ balanced salt solution 
(HBSS) containing 10 mM unlabelled thymidine 
(Sigma) and once more in HBSS alone. Washed 
islets were transferred to plastic tubes containing 
250 ,J distilled water and disrupted ultrasonically. 
Aliquots (150,J) of the homogenates were filtered 
through glass microfilters (Whatman) and the free 
[3H]thymidine washed off the discs with distilled 
water. The filter discs were then dried overnight at 
room temperature and the radioactivity retained 
was then determined by liquid scintillation spectro- 
metry. Duplicate aliquots of the homogenates (50 
~1) were taken for the estimation of DNA [9] and 
the incorporation of [3H]thymidine was expressed 
as dpm/ig DNA. P> 0.05: *** P<O.OOl. 
3. RESULTS 3.2. DNA synthesis 
3.1. Insulin release 
Fig. 1 reveals that glibenclamide 
significant stimulatory effect on 
(5 PM) had no 
insulin release 
from fetal islets cultured in 5.5 mM glucose. In 
contrast, under identical conditions, adult islets 
responded with a significant increase in insulin 
release. 
Table 1 shows that glibenclamide at 5 pM was 
without significant stimulatory effect on DNA syn- 
thesis in adult islets cultured at 5.5 mM glucose. 
Similarly, at concentrations of 2 and lOpM, it had 
no effect when the culture medium contained 11 
mM glucose. When fetal islets were treated with 
glibenclamide at 5 PM, there was a significant in- 
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Fig.1. Effect of glibenclamide (HB419) on insulin 
release from isolated fetal and adult rat pancreatic slets. 
Insulin release was measured during a 90-min incubation 
period. Bars indicate means + SE of the number of 
observations given in parentheses. Probability of chance 
differences between control, and treated islets. NS, 
Table 1 
Effects of glucose and glibenclamide on DNA synthesis in cultured rat pancreatis islets 
Additions to culture DNA synthesis (dpm//g DNA)a 
Adult Fetal 
Glucose (5.5 mM) 493 * 53 ( 5) 1710 + 179 ( 6) 
+ glibenclamide (5 PM) 65Ok 51 (5)NS 4364 + 807 ( 7)b 
Glucose (11 mM) 696 + 76 (28) _ 
+ glibenclamide (2 FM) 696 f 73 (21) NS _ 
+ glibenclamide (10 PM) 659 f 180 ( 8) NS _ 
Glucose (22 mM) - 2467 + 248 (10) 
+ glibenclamide (5 PM) _ 2864 f 472 ( 8) NS 
a Results are given as the means of the numbers of observations given in parentheses f SE. Pro- 
bability of the chance difference between control, and glibenclamide treated islets: NS, P> 0.05 
b P<O.O5 
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cultured at 5.5 but not at 22 mM glucose. More- 
over, fetal islets incorporated more t3H]thymidine 
than adult islets cultured under similar conditions 
(PC 0.001). Note also that the increase in the 
glucose concentration had a significant stimulatory 
effect on the incorporation of [3H]thymidine into 
fetal and adult islet DNA. 
4. DISCUSSION 
The observed increase in insulin release from 
adult rat islets in response to glibenclamide con- 
firms that this sulfonylurea retains its insulin- 
releasing properties under the present in vitro con- 
ditions. Failure of fetal islets to respond, with in- 
creased insulin release, to glibenclamide in vitro 
may reflect the immature state of their P-cells 
which are known to have a low insulin response to 
glucose after being maintained for a week at 5.6 
mM glucose [lo]. In [4], tolbutamide was found to 
enhance insulin release from monolayer cultures of 
neonatal rat pancreas, but the degree of enhance- 
ment (25%) was not statistically significant as 
reported here. 
dissociated functions when &cells are exposed to 
sulphonylureas in support of the conclusion in 
[12]. This is in contrast with glucose, which 
stimulated both functions in concert, acting as a 
nutrient to the P-cell [6]. The differences between 
glucose and the sulfonylureas may reflect that the 
effects of the latter could be mediated via 
mechanisms other than nutrient receptors in the fl- 
cells [3], and indicate that functional stimulation 
of these cells is not a prerequisite for increased 
replication. 
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